COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CRI - FR0000130692 - Common Stock
9.92 EUR
-0.08 (-0.8%)
Overall CRI gets a fundamental rating of 3 out of 10. We evaluated CRI against 14 industry peers in the Industrial Conglomerates industry. CRI has a bad profitability rating. Also its financial health evaluation is rather negative. CRI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
CRI had a positive operating cash flow in the past year.
Of the past 5 years CRI 4 years were profitable.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of 0.28%, CRI is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
With a Return On Equity value of 1.03%, CRI is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
CRI has a Return On Invested Capital of 5.17%. This is in the better half of the industry: CRI outperforms 64.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRI is below the industry average of 6.77%.
The last Return On Invested Capital (5.17%) for CRI is above the 3 year average (4.66%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.17% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.66%
ROIC(5y)5.49%
1.3 Margins
Looking at the Profit Margin, with a value of 0.37%, CRI is doing worse than 64.29% of the companies in the same industry.
CRI's Profit Margin has declined in the last couple of years.
CRI has a Operating Margin (6.43%) which is in line with its industry peers.
CRI's Operating Margin has been stable in the last couple of years.
CRI's Gross Margin of 28.51% is on the low side compared to the rest of the industry. CRI is outperformed by 78.57% of its industry peers.
CRI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.43% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.6%
OM growth 5Y1.35%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CRI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CRI has more shares outstanding
CRI has a better debt/assets ratio than last year.
2.2 Solvency
CRI has an Altman-Z score of 1.23. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.23, CRI is doing worse than 85.71% of the companies in the same industry.
CRI has a debt to FCF ratio of 136.13. This is a negative value and a sign of low solvency as CRI would need 136.13 years to pay back of all of its debts.
CRI has a Debt to FCF ratio of 136.13. This is in the lower half of the industry: CRI underperforms 71.43% of its industry peers.
A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.38, CRI is doing worse than 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 136.13 | ||
| Altman-Z | 1.23 |
ROIC/WACC0.84
WACC6.16%
2.3 Liquidity
A Current Ratio of 1.30 indicates that CRI should not have too much problems paying its short term obligations.
CRI has a Current ratio of 1.30. This is amonst the worse of the industry: CRI underperforms 92.86% of its industry peers.
A Quick Ratio of 0.85 indicates that CRI may have some problems paying its short term obligations.
CRI has a worse Quick ratio (0.85) than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.00%, which is quite impressive.
Measured over the past years, CRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.59% on average per year.
Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
CRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.10% yearly.
EPS 1Y (TTM)152%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-142.86%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 32.19% on average per year.
The Revenue is expected to grow by 3.45% on average over the next years.
EPS Next Y7.79%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 76.31 indicates a quite expensive valuation of CRI.
CRI's Price/Earnings ratio is a bit more expensive when compared to the industry. CRI is more expensive than 64.29% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.92. CRI is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 11.16 indicates a reasonable valuation of CRI.
Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than 78.57% of the companies in the same industry.
CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 76.31 | ||
| Fwd PE | 11.16 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 71.43% of the companies listed in the same industry.
CRI's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CRI is more expensive than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 79.65 | ||
| EV/EBITDA | 7.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CRI's earnings are expected to grow with 32.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.79
PEG (5Y)N/A
EPS Next 2Y41.87%
EPS Next 3Y32.19%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.30%, CRI has a reasonable but not impressive dividend return.
CRI's Dividend Yield is slightly below the industry average, which is at 3.20.
CRI's Dividend Yield is slightly below the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.3% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
118.52% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPA:CRI (12/29/2025, 3:10:03 PM)
9.92
-0.08 (-0.8%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners5.46%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap246.91M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts75
Price Target11.56 (16.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.3% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.85%
PT rev (3m)-11.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-26.51%
EPS NY rev (3m)-26.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)-2.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 76.31 | ||
| Fwd PE | 11.16 | ||
| P/S | 0.34 | ||
| P/FCF | 79.65 | ||
| P/OCF | 10.29 | ||
| P/B | 0.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.22 |
EPS(TTM)0.13
EY1.31%
EPS(NY)0.89
Fwd EY8.96%
FCF(TTM)0.12
FCFY1.26%
OCF(TTM)0.96
OCFY9.72%
SpS29.23
BVpS10.49
TBVpS-1.49
PEG (NY)9.79
PEG (5Y)N/A
Graham Number5.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROCE | 7.06% | ||
| ROIC | 5.17% | ||
| ROICexc | 6.16% | ||
| ROICexgc | 13.23% | ||
| OM | 6.43% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% | ||
| FCFM | 0.43% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.66%
ROIC(5y)5.49%
ROICexc(3y)5.71%
ROICexc(5y)7.48%
ROICexgc(3y)13.23%
ROICexgc(5y)17.05%
ROCE(3y)6.38%
ROCE(5y)7.54%
ROICexgc growth 3Y-6.07%
ROICexgc growth 5Y2.64%
ROICexc growth 3Y-7.28%
ROICexc growth 5Y-2.63%
OM growth 3Y1.6%
OM growth 5Y1.35%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 136.13 | ||
| Debt/EBITDA | 4.63 | ||
| Cap/Depr | 67.42% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.85% | ||
| Profit Quality | 114.82% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.23 |
F-Score7
WACC6.16%
ROIC/WACC0.84
Cap/Depr(3y)58.97%
Cap/Depr(5y)54.86%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-142.86%
EPS Next Y7.79%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y58.11%
EBIT growth 3Y1.28%
EBIT growth 5Y4.5%
EBIT Next Year104.23%
EBIT Next 3Y38.23%
EBIT Next 5YN/A
FCF growth 1Y108.81%
FCF growth 3Y-17.63%
FCF growth 5Y170.57%
OCF growth 1Y245.46%
OCF growth 3Y-11.49%
OCF growth 5Y12.03%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
Can you provide the valuation status for COMPAGNIE CHARGEURS INVEST?
ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
What is the financial health of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.
Can you provide the expected EPS growth for CRI stock?
The Earnings per Share (EPS) of COMPAGNIE CHARGEURS INVEST (CRI.PA) is expected to grow by 7.79% in the next year.